Cellular and molecular mechanisms of photodynamic hypericin therapy for nasopharyngeal carcinoma cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 334, Issue 3, 2010, Pages 847-853

  Wang, Xiaoli ^b   Guo, Yi ^a   Yang, Shu ^a   Wang, Caihong ^b   Fu, Xuping ^a   Wang, Jinling ^b   Mao, Yumin ^a   Zhang, Junsong ^b   Li, Yao ^a  

^a FUDAN UNIVERSITY   (China)

^b SHENZHEN POLYTECHNIC   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; GLUTATHIONE; HYPERICIN; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; CASPASE; PERYLENE; RADIOSENSITIZING AGENT;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA REPAIR; DNA REPLICATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIGHT EMITTING DIODE; MITOCHONDRIAL MEMBRANE; NASOPHARYNX CARCINOMA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; CELL SURVIVAL; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; LIGHT; METABOLISM; MITOCHONDRION; NASOPHARYNGEAL NEOPLASMS; PHOTOCHEMOTHERAPY; PROCEDURES; RADIATION RESPONSE; TUMOR CELL LINE;

APOPTOSIS; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DNA REPAIR; DNA REPLICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; GLUTATHIONE; HUMANS; LIGHT; MITOCHONDRIA; NASOPHARYNGEAL NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERYLENE; PHOTOCHEMOTHERAPY; RADIATION-SENSITIZING AGENTS; REACTIVE OXYGEN SPECIES;

EID: 77956260417     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.168856     Document Type: Article

References (37)

1. Agostinis P, Vantieghem A, Merlevede W, and de Witte PA (2002) Hypericin in cancer treatment: more light on the way. Int J Biochem Cell Biol 34:221-241.
2. Ali SM and Olivo M (2002) Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells. Int J Oncol 21:531-540.
3. Ali SM, Chee SK, Yuen GY, and Olivo M (2002) Hypericin induced death receptor-mediated apoptosis in photoactivated tumor cells. Int J Mol Med 9:601-616.
4. Ali SM, Olivo M, Yuen GY, and Chee SK (2001) Induction of apoptosis by Hypericin through activation of caspase-3 in human carcinoma cells. Int J Mol Med 8:521-530.
5. Alvarez MG, Morán F, Yslas EI, Vittar NB, Bertuzzi M, Durantini EN, and Rivarola V (2003) Pharmacokinetic and tumour-photosensitizing properties of methoxyphenyl porphyrin derivative. Biomed Pharmacother 57:163-168.
6. Blank M, Kostenich G, Lavie G, Kimel S, Keisari Y, and Orenstein A (2002) Wavelength-dependent properties of photodynamic therapy using hypericin in vitro and in an animal model. Photochem Photobiol 76:335-340.
7. Bras M, Queenan B, and Susin SA (2005) Programmed cell death via mitochondria: different modes of dying. Biochemistry 70:231-239. (Pubitemid 40512332)
8. Buytaert E, Dewaele M, and Agostinis P (2007) Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta 1776:86-107.
9. Buytaert E, Matroule JY, Durinck S, Close P, Kocanova S, Vandenheede JR, de Witte PA, Piette J, and Agostinis P (2008) Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells. Oncogene 27:1916-1929.
10. Chen JY, Cheung NH, Fung MC, Wen JM, Leung WN, and Mak NK (2000) Subcellular localization of merocyanine 540 (MC540) and induction of apoptosis in murine myeloid leukemia cells. Photochem Photobiol 72:114-120.
11. Cole CD, Liu JK, Sheng X, Chin SS, Schmidt MH, Weiss MH, and Couldwell WT (2008) Hypericin-mediated photodynamic therapy of pituitary tumors: preclinical study in a GH4C1 rat tumor model. J Neurooncol 87:255-261.
12. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, and Conklin BR (2002) GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 31:19-20.
13. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, and Conklin BR (2003) MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 4:R7.
14. Du HY, Olivo M, Tan BK, and Bay BH (2003) Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer. Int J Oncol 23:1401-1405.
15. Eisen MB, Spellman PT, Brown PO, and Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868.
16. Falk H (1999) From the photosensitizer hypericin to the photoreceptor stentorin- the chemistry of phenanthroperylene quinones. Angew Chem Int Ed Engl 38:3116-3136.
17. Ferenc P, Solar P, Kleban J, Mikes J and Fedorocko P (2010) Down-regulation of Bcl-2 and Akt induced by combination of photoactivated hypericin and genistein in human breast cancer cells. J Photochem Photobiol B 98:25-34.
18. Fiers W, Beyaert R, Declercq W, and Vandenabeele P (1999) More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 18:7719-7730.
19. Green DR and Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305:626-629.
20. Höpfner M, Maaser K, Theiss A, Lenz M, Sutter AP, Kashtan H, von Lampe B, Riecken EO, Zeitz M, and Scherübl H (2003) Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells. Int J Colorectal Dis 18:239-247.
21. Kersten B, Zhang J, Brendler-Schwaab SY, Kasper P, and Müller L (1999) The application of the micronucleus test in Chinese hamster V79 cells to detect drug-induced photogenotoxicity. Mutat Res 445:55-71.
22. Kiesslich T, Krammer B, and Plaetzer K (2006) Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. Curr Med Chem 13:2189-2204.
23. Kocanova S, Buytaert E, Matroule JY, Piette J, Golab J, de Witte P, and Agostinis P (2007) Induction of heme-oxygenase 1 requires the p38MAPK and PI3K pathways and suppresses apoptotic cell death following hypericin-mediated photodynamic therapy. Apoptosis 12:731-741.
24. Mikes J, Koval' J, Jendzelovský R, Sacková V, Uhrinová I, Kello M, Kuliková L, and Fedorocko P (2009) The role of p53 in the efficiency of photodynamic therapy with hypericin and subsequent long-term survival of colon cancer cells. Photochem Photobiol Sci 8:1558-1567.
25. Okpanyi SN, Lidzba H, Scholl BC, and Miltenburger HG (1990) Genotoxicity of a standardized Hypericum extract. Arzneimittelforschung 40:851-855.
26. Roscetti G, Franzese O, Comandini A, and Bonmassar E (2004) Cytotoxic activity of Hypericum perforatum L. on K562 erythroleukemic cells: differential effects between methanolic extract and hypericin. Phytother Res 18:66-72.
27. Sanovic R, Krammer B, Grumboeck S, and Verwanger T (2009) Time-resolved gene expression profiling of human squamous cell carcinoma cells during the apoptosis process induced by photodynamic treatment with hypericin. Int J Oncol 35:921-939.
28. Sarközi R, Perco P, Hochegger K, Enrich J, Wiesinger M, Pirklbauer M, Eder S, Rudnicki M, Rosenkranz AR, Mayer B, et al. (2008) Bortezomib-induced survival signals and genes in human proximal tubular cells. J Pharmacol Exp Ther 327:645-656.
29. Schneider-Yin X, Kurmanaviciene A, Roth M, Roos M, Fedier A, Minder EI, and Walt H (2009) Hypericin and 5-aminolevulinic acid-induced protoporphyrin IX induce enhanced phototoxicity in human endometrial cancer cells with non-coherent white light. Photodiagnosis Photodyn Ther 6:12-18.
30. Seitz G, Krause R, Fuchs J, Heitmann H, Armeanu S, Ruck P, and Warmann SW (2008) In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin. Oncol Rep 20:1277-1282.
31. Seitz G, Warmann SW, Armeanu S, Heitmann H, Ruck P, Hoffman RM, Fuchs J, and Wessels JT (2007) In vitro photodynamic therapy of childhood rhabdomyosarcoma. Int J Oncol 30:615-620.
32. Sun YX, Meng Y, Dong Z, and Yang ZQ (2005) Effects of hypericin associated with light irradiation on human laryngeal squamous cell carcinoma strain Hep-2. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 40:128-132.
33. Theodossiou TA, Hothersall JS, De Witte PA, Pantos A, and Agostinis P (2009) The multifaceted photocytotoxic profile of hypericin. Mol Pharm 6:1775-1789.
34. Theodossiou TA, Papakyriakou A, and Hothersall JS (2008) Molecular modeling and experimental evidence for hypericin as a substrate for mitochondrial complex III; mitochondrial photodamage as demonstrated using specific inhibitors. Free Radic Biol Med 45:1581-1590.
35. Thong PSP, Watt F, Ren MQ, Soo KC, and Olivo M (2005) Investigating the role of calcium and biological trace elements in hypericin photodynamic therapy induced tumor cell death using nuclear microscopy. Nucl Instrum Methods Phys Res B 231:315-320.
36. Watts GS, Futscher BW, Isett R, Gleason-Guzman M, Kunkel MW, and Salmon SE (2001) cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways. J Pharmacol Exp Ther 299:434-441.
37. Zoratti M, Szabò I, and De Marchi U (2005) Mitochondrial permeability transitions: how many doors to the house? Biochim Biophys Acta 1706:40-52.